Yuankai Shi

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Yuankai Shi is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in health sciences, cancer therapeutics, and clinical trials.

Top concepts

HealthMedicineOncologyPathologyLung CancerCancer TherapyClinical TrialsRadiation Oncology

Publications per year

2022–2024

Publications

Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial

Baohui Han, Trevor Feinstein, Yuankai Shi et al. · The Lancet Respiratory Medicine · 2024 · 17 citations

Oncology, Advanced Lung Disease, Docetaxel Versus Docetaxel +10

Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC

Shasha Wang, Ning Lou, Rongrong Luo et al. · Journal of Translational Medicine · 2022 · 16 citations · Full text

1–2 of 2